Ocular medicines in children: the regulatory situation related to clinical research
<p>Abstract</p> <p>Background</p> <p>Many ocular medications are prescribed for paediatric patients, but the evidence for their rational use is very scant. This study was planned to compare the availability and the licensing status of ocular medications marketed in Ital...
Main Authors: | Fortinguerra Filomena, Clavenna Antonio, Bonati Maurizio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2431/12/8 |
Similar Items
-
Nanotechnology-based strategies for treatment of ocular disease
by: Yuhua Weng, et al.
Published: (2017-05-01) -
Microneedle-based ocular drug delivery systems – recent advances and challenges
by: Piotr Gadziński, et al.
Published: (2022-10-01) -
Hydrogels for ocular drug delivery and tissue engineering
by: Marzieh Fathi, et al.
Published: (2015-12-01) -
Ocular manifestations of liver disease in children: Clinical aspects and implications
by: Durga Prasad, et al.
Published: (2020-11-01) -
Cannabinoid-Based Ocular Therapies and Formulations
by: Sofia M. Saraiva, et al.
Published: (2023-03-01)